GRECO, ELISABETTA
 Distribuzione geografica
Continente #
NA - Nord America 11.137
AS - Asia 1.356
EU - Europa 1.327
SA - Sud America 182
Continente sconosciuto - Info sul continente non disponibili 94
AF - Africa 19
OC - Oceania 5
Totale 14.120
Nazione #
US - Stati Uniti d'America 11.064
SG - Singapore 587
IT - Italia 309
CN - Cina 287
RU - Federazione Russa 177
DE - Germania 173
FR - Francia 166
VN - Vietnam 157
UA - Ucraina 142
BR - Brasile 141
HK - Hong Kong 121
IE - Irlanda 95
FI - Finlandia 84
GB - Regno Unito 72
JP - Giappone 49
BD - Bangladesh 37
CA - Canada 32
KR - Corea 27
SE - Svezia 27
NL - Olanda 24
IN - India 23
PL - Polonia 18
ID - Indonesia 11
MX - Messico 11
AR - Argentina 10
ZA - Sudafrica 10
EC - Ecuador 8
TR - Turchia 8
VE - Venezuela 8
AT - Austria 7
IQ - Iraq 7
JM - Giamaica 7
CO - Colombia 6
ES - Italia 6
RO - Romania 6
AE - Emirati Arabi Uniti 5
AU - Australia 5
BE - Belgio 5
IR - Iran 4
LT - Lituania 4
PH - Filippine 4
SV - El Salvador 4
TT - Trinidad e Tobago 4
CL - Cile 3
EE - Estonia 3
GT - Guatemala 3
HN - Honduras 3
MY - Malesia 3
OM - Oman 3
PK - Pakistan 3
SA - Arabia Saudita 3
UY - Uruguay 3
UZ - Uzbekistan 3
AL - Albania 2
AZ - Azerbaigian 2
CH - Svizzera 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
EU - Europa 2
IL - Israele 2
KG - Kirghizistan 2
KW - Kuwait 2
MA - Marocco 2
MD - Moldavia 2
NI - Nicaragua 2
PS - Palestinian Territory 2
TW - Taiwan 2
AW - Aruba 1
BF - Burkina Faso 1
BS - Bahamas 1
BZ - Belize 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
EG - Egitto 1
GA - Gabon 1
GN - Guinea 1
GR - Grecia 1
KH - Cambogia 1
NG - Nigeria 1
PE - Perù 1
PY - Paraguay 1
SK - Slovacchia (Repubblica Slovacca) 1
SR - Suriname 1
TH - Thailandia 1
TN - Tunisia 1
Totale 14.028
Città #
Woodbridge 2.983
Wilmington 2.695
Houston 2.321
Singapore 391
Ashburn 374
Ann Arbor 280
Chandler 212
San Jose 179
Fairfield 168
Jacksonville 130
Hong Kong 118
Beijing 113
New York 98
Dublin 94
Seattle 88
Council Bluffs 87
Dallas 72
Medford 62
Cambridge 61
The Dalles 60
Santa Clara 59
Los Angeles 56
Ho Chi Minh City 54
Rome 52
Helsinki 51
Dearborn 40
Hanoi 35
Tokyo 31
Lawrence 30
São Paulo 28
Moscow 26
Zhengzhou 25
Boardman 24
Denver 21
Buffalo 20
Milan 20
Mülheim 20
Chicago 19
Alexandria 15
London 15
Lauterbourg 14
Orem 14
Menlo Park 13
Frankfurt am Main 12
Monte Porzio Catone 12
San Diego 12
Phoenix 11
Palo Alto 10
Guangzhou 9
Toronto 9
Amsterdam 8
Brooklyn 8
Chennai 8
Johannesburg 8
Munich 8
Nanjing 8
Warsaw 8
Naples 7
North Bergen 7
Washington 7
Atlanta 6
Baghdad 6
Bologna 6
Da Nang 6
Dong Ket 6
Haiphong 6
Manchester 6
Mumbai 6
Newark 6
Norwalk 6
Nuremberg 6
University Park 6
Vancouver 6
Boston 5
Brussels 5
Del Norte 5
Detroit 5
Jakarta 5
Kraków 5
Kunming 5
Miami 5
Poplar 5
Richmond 5
Saint Petersburg 5
Stockholm 5
Adro 4
Brescia 4
Dubai 4
Hefei 4
Kingston 4
Lappeenranta 4
Mexico City 4
Montreal 4
Mountain View 4
Perugia 4
Queens 4
Redondo Beach 4
Redwood City 4
Salt Lake City 4
San Salvador 4
Totale 11.618
Nome #
Complement and autoimmunity 549
Genetica dell’atopia 541
Intravenous immunoglobulin therapy in pregnant patients affected with systemic lupus erythematosus and recurrent spontaneous abortion 521
C3 come indicatore di efficacia terapeutica in pazienti con artrite reumatoide in terapia con inibitori del TNFα 520
A study of Adenosine-Deaminase genetic polymorphism in rheumatoid arthritis 516
An impaired endothelial dependent and independent vasodilation characterizes the myo-endothelial dysfunction in ssc patients 513
Skin testing correlates negatively with high-activity ACP1 *B/*C genotype 507
Anti-thyroid antibodies and antiphospholipid syndrome: Evidence of reduced fecundity and of poor pregnancy outcome in recurrent spontaneous aborters 504
Complement system in rheumatoid arthritis: evidence of correlation with disease activity but not with anti-citrullinated protein antibodies 473
Sistema complementare e artrite reumatoide: Correlazioni con autoanticorpi, caratteristiche cliniche e di laboratorio e farmaci anti-TNF α 470
Recurrent Angioedema: Occurrence, Features, and Concomitant Diseases in an Italian Single-Center Study 467
Complement system in psoriatic arthritis: a useful marker in response prediction and monitoring of anti-TNF treatment. 465
Scleroderma heart involvement: non-invasive assessment of pathophysiological mechanism and its effect on prognosis 460
Lysophosphatidic acid enhances antimycobacterial activity both in vitro and ex vivo 454
ADA genetic polymorphism and total plasma IgE level in healthy adults 451
Complement system and rheumatoid arthritis: relationships with autoantibodies, serological, clinical features, and anti-TNF treatment 450
Inhibition of the complement system by glutathione: molecular mechanisms and potential therapeutic implications 437
Genetica delle malattie allergiche 432
Genetic control of serum IgE levels: a study of low molecular weight protein tyrosine phosphatase. 430
IL-4 receptor alpha chain genetic polymorphism and total IgE levels in the English population: two-locus haplotypes are more informative than individual SNPs 429
Exploiting immunotherapy in Mycobacterium tuberculosis-infected mice: sphingosine 1-phosphate treatment results in a protective or detrimental effect depending on the stage of infection 425
Morphometric analysis of capillaroscopic images during psoriatic arthritis: comparison with rheumatoid artrhitis 420
Comment on: Intravenous immunoglobulin therapy in pregnant patients affected with systemic lupus erythematosus and recurrent spontaneous abortion: reply 420
CpG oligodeoxynucleotides induce Ca2+-dependent phospholipase D activity leading to phagolysosome maturation and intracellular mycobacterial growth inhibition in monocytes 416
Low molecular weight PTP-IL-4RA interaction in atopy predisposition 403
Natural killer and b cells in patients with rheumatoid arthritis and psoriatic arthritis treated with etanercept 391
The complex interplay between rheumatoid arthritis and atopy: Focus on anti-TNFα treatment 391
Systemic sclerosis: Exploring the potential interplay between thyroid disorders and pregnancy outcome in an Italian cohort 364
Omalizumab and adalimumab: a winning couple 158
Safety and efficacy of secukinumab treatment in a patient with ankylosing spondylitis and concomitant multiple sclerosis: a commentary 140
The steroid-sparing effect of JAK inhibitors across multiple patient populations 135
How Has Molecular Biology Enhanced Our Undertaking of axSpA and Its Management 123
Rheumatologist's Perspective on Non-Infectious Uveitis: Patterns from Tertiary Referral Rheumatologic Clinics in Italy 119
What's new and what's next for biological and targeted synthetic treatments in psoriatic arthritis? 115
Human Leukocyte Antigen (HLA) Typing Study Identifies Maternal DQ2 Susceptibility Alleles among Infertile Women: Potential Associations with Autoimmunity and Micronutrients 97
Kinesiophobia as part of the psychological burden in Spondyloarthritis: a case-control study 96
Subclinical microvascular changes in ANCA-vasculitides: the role of optical coherence tomography angiography and nailfold capillaroscopy in the detection of disease-related damage 82
Risankizumab Efficacy in Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis (SAPHO) Remission: A Case Report on Rheumatologic and Dermatologic Disease Manifestations with Literature Review 79
How reflectance confocal microscopy can be used in systemic sclerosis skin diagnosis 70
Pregnancy in women with Hereditary Angioedema due to C1-inhibitor deficiency: Results from the ITACA cohort study on outcome of mothers and children with in utero exposure to plasma-derived C1-inhibitor 65
Subclinical ocular microvascular involvement in primary antiphospholipid syndrome and antiphospholipid antibody carriers 22
Totale 14.120
Categoria #
all - tutte 33.039
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.039


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022191 0 0 0 24 5 14 10 11 15 21 14 77
2022/2023529 34 48 11 78 47 127 50 27 56 5 35 11
2023/2024265 29 8 5 3 41 71 3 24 11 19 18 33
2024/2025912 37 219 107 62 34 62 70 51 71 64 74 61
2025/20261.893 123 91 227 201 188 89 266 198 206 179 74 51
2026/2027713 93 76 353 191 0 0 0 0 0 0 0 0
Totale 14.120